tiprankstipranks
STRATEC Biomedical AG (DE:SBS)
XETRA:SBS
Holding DE:SBS?
Track your performance easily

STRATEC Biomedical (SBS) Stock News & Sentiment

3 Followers
0RAR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0RAR Earnings this Week: How Will it Perform?
2M ago
STRATEC Biomedical (0RAR) is scheduled to report 3rd quarter earnings on 10/25/2024, before the market opens. Regarding Q3 estimates, Wall Street analysts expect STRATEC Biomedical to post earnings of €0.38 ...Read more
German Market Update: Three Shares to Buy Today
Premium
Global Markets
German Market Update: Three Shares to Buy Today
2y ago

News Score - Last 7 Days

Neutral
DE:SBS
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:SBS’s Media Buzz Sentiment?
2 articles about DE:SBS were published this week. In an average week, 1 articles are published.
    What is DE:SBS’s weekly average amount of articles?
    In an average week, 1 articles about DE:SBS are published.
      What is DE:SBS’s News Sentiment?
      50% of articles about DE:SBS were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        CLGNCollplant Holdings
        IVIXDInvion
        SRPTSarepta Therapeutics
        FARNFaron Pharmaceuticals Oy
        LVCLFLiving Cell Technologies Ltd.
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis